Company / Revenue
InspireMD, Inc. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$7.0M
FY2025
5-year range
$2.5M / $7.0M
FY2021-FY2025
Trend
+13.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue has increased for 4 consecutive years, from $2M in FY2021 to $7M in FY2025.
Based on SEC 10-K filings.
$7M in FY2025 with a 5-year CAGR of +13.5%.
Improved from $5M to $7M over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- +16.0%
- 5-Year CAGR
- +13.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- InspireMD, Inc.'s revenue has grown for 4 consecutive years.
- 5-year CAGR of +13.5%, indicating consistent growth.
- In FY2025, revenue increased 13.0% year-over-year.
- Lowest revenue in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.42 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $7.0M | +13.0% |
| FY2024 | $6.2M | +20.0% |
| FY2023 | $5.2M | +15.0% |
| FY2022 | $4.5M | +80.9% |
| FY2021 | $2.5M | -33.2% |
| FY2020 | $3.7M | +3.3% |
| FY2019 | $3.6M | +30.4% |
| FY2018 | $2.8M | +45.8% |
| FY2017 | $1.9M | -18.0% |
| FY2016 | $2.3M | -18.0% |
As of FY2025 · SEC 10-K Annual Filings · Last checked Jun 28, 2026